Tapewire

Nasdaq · USD

XENE

Xenon Pharmaceuticals Inc.

Export transactions ↓
Tapewire entity
2602
SEC CIK
0001582313
Parsed reports
275

Last 12 months

Inside the activity.

2 purchase rows · 26 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202602
Feb 202600
Mar 2026015
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202603
Sep 202620
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 12, 2016 Filed Dec 13, 2016 16:57 UTC Exercise / conversionCommon Shares 14,403 $3.21 $46,233.63
Disclosure

SEC source: 0001171843-16-013622 · formfour.xml · nonDerivative · entry 1

TARNOW MICHAEL M · CIK 0001263647 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.

Read SEC document
December 06, 2016 Filed Dec 8, 2016 21:52 UTC
PATOU GARYDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 12,345 $0.00 Strike: $3.21 $0.00
Disclosure

SEC source: 0001171843-16-013554 · form4patou.xml · derivative · entry 3

PATOU GARY · CIK 0001283535 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 12,345 shares

Expires 2016-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.

F4 · derivative.exercise_date: The shares subject to the option fully vested on December 31, 2009.

Read SEC document
December 06, 2016 Filed Dec 8, 2016 21:52 UTC
PATOU GARYDirector
Tax withholdingCommon Shares 4,403 $7.90 $34,783.70
Disclosure

SEC source: 0001171843-16-013554 · form4patou.xml · nonDerivative · entry 2

PATOU GARY · CIK 0001283535 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,028

F2 · shares: Pursuant to the terms of a Lock-up Agreement executed by the Reporting Person in favor of the underwriters of the Company's Public Offering in September 2016 (the "Lock-up"), the Company withheld the number of shares set forth above pursuant to a net settlement permitted under the terms of the Lock-up. No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of the Lock-up.

F3 · price: Represents the closing price of the Company's common shares in U.S. dollars on December 5, 2016, which was converted to a Canadian dollar amount for purposes of net settlement calculations.

Read SEC document
December 06, 2016 Filed Dec 8, 2016 21:52 UTC
PATOU GARYDirector
Exercise / conversionCommon Shares 12,345 $3.21 $39,627.45
Disclosure

SEC source: 0001171843-16-013554 · form4patou.xml · nonDerivative · entry 1

PATOU GARY · CIK 0001283535 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,431

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.

Read SEC document
December 01, 2016 Filed Dec 2, 2016 18:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 12,345 $0.00 Strike: $3.21 $0.00
Disclosure

SEC source: 0001171843-16-013465 · f4_azab120216.xml · derivative · entry 3

AZAB MOHAMMAD · CIK 0001309653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 12,345 shares

Expires 2016-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.

F4 · derivative.exercise_date: The shares subject to the option fully vested on December 31, 2009.

Read SEC document
December 01, 2016 Filed Dec 2, 2016 18:05 UTC Tax withholdingCommon Shares 4,408 $7.80 $34,382.40
Disclosure

SEC source: 0001171843-16-013465 · f4_azab120216.xml · nonDerivative · entry 2

AZAB MOHAMMAD · CIK 0001309653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,875

F2 · shares: Pursuant to the terms of a Lock-up Agreement executed by the Reporting Person in favor of the underwriters of the Company's Public Offering in September 2016 (the "Lock-up"), the Company withheld the number of shares set forth above pursuant to a net settlement permitted under the terms of the Lock-up. No shares were sold by the Reporting Person in connection with the exercise and the common shares issued as a result of the exercise are subject to the terms of the Lock-up.

F3 · price: Represents the closing price of the Company's common shares in U.S. dollars on November 30, 2016, which was converted to a Canadian dollar amount for purposes of net settlement calculations.

Read SEC document
December 01, 2016 Filed Dec 2, 2016 18:05 UTC Exercise / conversionCommon Shares 12,345 $3.21 $39,627.45
Disclosure

SEC source: 0001171843-16-013465 · f4_azab120216.xml · nonDerivative · entry 1

AZAB MOHAMMAD · CIK 0001309653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,283

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.

Read SEC document
September 27, 2016 Filed Sep 27, 2016 23:03 UTC GrantStock Option (Right to Buy) · Derivative 5,144 $0.00 Strike: $8.15 $0.00
Disclosure

SEC source: 0001171843-16-012294 · f4_svoronos092716.xml · derivative · entry 1

Svoronos Dawn · CIK 0001574579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,144

Underlying: Common Shares · 5,144 shares

Expires 2026-09-26

F1 · derivative.exercise_date: One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, and the balance of the total shares subject to the Option shall vest on the three year anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.